Phibro Animal Health Corporation

Healthcare

NASDAQ:PAHC · NASDAQ Global Market

Market Cap $1.26B Beta 0.46 P/E (TTM) 13.4

$31.53 +0.86%

+$0.27 today

52W Low $23.57High $60.08

Vol 0.18M · Avg 0.37M

EPS (TTM)$2.35

Div Yield1.52%

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+33.43%

Period High

$59.33

Period Low

$23.58

Latest

$31.53

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Organon & Co.

NYSE:OGN

$3.53B

Avadel Pharmaceuticals plc

AVDL

$2.12B

Aurinia Pharmaceuticals Inc.

NASDAQ:AUPH

$2.03B

Pediatrix Medical Group, Inc.

NYSE:MD

$2.00B

ANI Pharmaceuticals, Inc.

NASDAQ:ANIP

$1.86B

Alvotech

NASDAQ:ALVO

$1.30B

MannKind Corporation

NASDAQ:MNKD

$1.13B

Evotec SE

NASDAQ:EVO

$966.11M

Tilray Brands, Inc.

NASDAQ:TLRY

$595.63M

BGM Group Ltd.

NASDAQ:BGM

$75.23M

What is the latest PAHC filing?

The latest filing shown is 4 dated Jun 2, 2026.

How many recent filings does PAHC have?

Intrinsic Alpha currently shows 20 recent filings for PAHC.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.